Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

55 trials with published results (10%)

Research Maturity

276 completed trials (51% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.9%

32 terminated out of 545 trials

Success Rate

89.6%

+3.0% vs benchmark

Late-Stage Pipeline

19%

106 trials in Phase 3/4

Results Transparency

20%

55 of 276 completed with results

Key Signals

55 with results90% success32 terminated

Data Visualizations

Phase Distribution

371Total
Not Applicable (174)
Early P 1 (3)
P 1 (29)
P 2 (59)
P 3 (43)
P 4 (63)

Trial Status

Completed276
Recruiting83
Unknown82
Terminated32
Not Yet Recruiting24
Withdrawn18

Trial Success Rate

89.6%

Benchmark: 86.6%

Based on 276 completed trials

Clinical Trials (545)

Showing 20 of 20 trials
NCT07855913Not ApplicableRecruiting

EUS-Guided Coil and Glue vs Glue Injection for Bleeding Gastric Varices in Cirrhosis

NCT05832229Phase 2RecruitingPrimary

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

NCT03225677RecruitingPrimary

Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis

NCT06000748Phase 2Terminated

NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients

NCT02400216CompletedPrimary

Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis

NCT06867731Completed

Endosonographic Shear Wave Elastography to Assess Liver and Splenic Fibrosis

NCT07820917Not ApplicableNot Yet RecruitingPrimary

Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis

NCT06316869Recruiting

Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch Viscoelastography

NCT07652203Not ApplicableNot Yet RecruitingPrimary

Impact of Propranolol on the Prognosis of Patients With Decompensated Cirrhosis and MELD Score > 9

NCT06007846Phase 2Recruiting

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

NCT05726032Phase 2RecruitingPrimary

Empagliflozin in Patients With Cirrhosis and Ascites

NCT05045482Phase 1Recruiting

Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease

NCT06863012Not ApplicableRecruiting

EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG

NCT07810855Not Yet RecruitingPrimary

Using Bedside Ultrasound to Understand Fluid Management in Patients With Chronic Liver Disease

NCT05484206Phase 1Completed

Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434

NCT02968810Phase 2CompletedPrimary

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

NCT07797101Not ApplicableNot Yet RecruitingPrimary

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

NCT06932783Not ApplicableActive Not RecruitingPrimary

Remote Electrical Stimulation for Pain and Depression Treatment in Cirrhosis

NCT06052176Phase 2Active Not RecruitingPrimary

Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement

NCT05548452Phase 1Active Not Recruiting

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

Scroll to load more

Research Network

Activity Timeline